Micrometastasis Breast Cancer
1 clinical trials · Condition
◉ Watch Micrometastasis Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (NCT04569747) | Dana-Farber Cancer Institute | 2021-01-11 |
Track Micrometastasis Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.